A synthetic version of testosterone commonly prescribed in hormone replacement treatment, for men suffering from testosterone levels, originally introduced in the 1950s. This ester allows for slower absorption and a more sustained release of testosterone compared to non-esterified forms. Developed by Schering, the first brand of this drug to be sold in the U.S. was Delatestryl® by Squibb, which has changed hands several times and is currently owned by Endo Pharmaceuticals. Outside the United States, the most prominent brand of testosterone enanthate is Testoviron®, a drug that has seen uninterrupted production for over 50 years and is now owned by Bayer. In both clinical and sports environments alike this substance is well liked for its ability to boost muscle maintenance and enhance performance without causing side effects related to estrogen like retaining water.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For more details consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.